Robin Reschke, physician scientist at the University Hospital Heidelberg, shared a post on LinkedIn:
“Feeling honored to be a Fellow of Cancer Core Europe’s (CCE) Training program for Young leaders in Translational Cancer research (TRYTRAC). It was an absolute pleasure to welcome the other TRYTRAC participants here in Heidelberg for the second meeting. A special thank you to Prof. Dr. med. Jessica Hassel, who encouraged me to get involved in the program in the first place. It was especially inspiring to hear Stefan Fröhling reflect on the history of DKFZ, DKTK and the expansion of the NCT. He has also played a pivotal role in shaping and advancing the Cancer Core Europe Consortium. Hats off!
Proud to contribute to this community and excited for the impact this next generation of translational cancer researchers will make across Cancer Core Europe. Looking forward to spend more time with these bright researchers at the other National Tumor Centers in Milano, Barcelona, Amsterdam and Paris. First potential collabs will be discussed in Paris in two weeks with former and current TRYTRAC.”
More posts featuring Robin Reschke on OncoDaily.
